OTCMKTS:BLOZF Cannabix Technologies (BLOZF) Stock Price, News & Analysis $0.48 +0.01 (+3.24%) As of 02:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsHeadlinesShort InterestBuy This Stock About Cannabix Technologies Stock (OTCMKTS:BLOZF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Cannabix Technologies alerts:Sign Up Key Stats Today's Range$0.46▼$0.4950-Day Range$0.37▼$0.6452-Week Range$0.33▼$0.68Volume75,864 shsAverage Volume69,668 shsMarket Capitalization$58.35 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Cannabix Technologies Inc. is a Canada-based developer of biosensor technologies focused on the rapid, non-invasive detection of cannabis impairment. The company’s flagship product is a handheld breathalyzer device designed to identify recent use of tetrahydrocannabinol (THC) within minutes of exhalation, offering law enforcement agencies, public safety organizations and workplace safety departments a potential tool to assess impairment in real time. The Cannabix breathalyzer employs proprietary sensor arrays and on-board algorithms to distinguish THC molecules in breath samples, delivering results without the need for laboratory analysis. In addition to its cannabis detection platform, the company is exploring integration of alcohol and multi-drug screening capabilities to create a more comprehensive roadside and occupational testing solution. Cannabix has pursued partnerships with research institutions and regulatory bodies to validate its technology under controlled conditions. Headquartered in Vancouver, British Columbia, Cannabix Technologies conducts its research and development activities at its Canadian laboratories and collaborates with external contract manufacturers for product assembly. The company’s management team is led by Chief Executive Officer Craig Ellins, who brings experience in technology commercialization and regulatory affairs. The board and executive suite also include professionals with backgrounds in biosensor engineering, public safety and diagnostics marketing. As a publicly traded entity on the OTC Markets under the symbol BLOZF, Cannabix Technologies continues to advance its prototype toward regulatory approval and commercial rollout. Its primary markets include North America and select international jurisdictions considering roadside and workplace drug screening solutions, with ongoing efforts to secure government contracts and private-sector distribution agreements.AI Generated. May Contain Errors. Read More Receive BLOZF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cannabix Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BLOZF Stock News HeadlinesCannabix Marijuana Breath Test Achieves Major Milestone: Breath Collection Unit Secures UL and CSA CertificationsMay 13, 2026 | globenewswire.comCannabix Technologies Announces Delivery of Marijuana Breath Test (MBT) to Workplace Drug and Alcohol Testing ClinicMay 4, 2026 | globenewswire.comTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.May 21 at 1:00 AM | Reagan Gold Group (Ad)Omega Laboratories to Host Educational Panels and Present Cannabix Marijuana Breath Test Solution at the 2026 NDASA Conference in CaliforniaApril 20, 2026 | globenewswire.comCannabix Technologies Announces Delivery of Marijuana Breath Test (MBT) to Virginia based Industrial Manufacturing ClientApril 1, 2026 | globenewswire.comCannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction ClientMarch 19, 2026 | globenewswire.comCannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT)March 16, 2026 | globenewswire.comJournal of Analytical Toxicology Publishes Peer‑Reviewed Validation Study Demonstrating Accuracy of Omega Laboratories' Test Method for Detecting Marijuana in Breath Samples Using Cannabix Technologies' Breath Collection UnitMarch 3, 2026 | prnewswire.comSee More Headlines BLOZF Stock Analysis - Frequently Asked Questions How have BLOZF shares performed this year? Cannabix Technologies' stock was trading at $0.4370 at the beginning of the year. Since then, BLOZF stock has increased by 8.7% and is now trading at $0.4750. How were Cannabix Technologies' earnings last quarter? Cannabix Technologies Inc. (OTCMKTS:BLOZF) announced its quarterly earnings results on Tuesday, December, 30th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business had revenue of $0.09 million for the quarter. How do I buy shares of Cannabix Technologies? Shares of BLOZF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings12/30/2025Today5/21/2026Fiscal Year End4/30/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorBusiness Services Industry Technology Services Sub-IndustryN/A Current SymbolOTCMKTS:BLOZF CIKN/A Webwww.cannabixtechnologies.com Phone604-551-7831Fax604-676-2767EmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)($0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$3.36 million Net MarginsN/A Pretax Margin-3,920.00% Return on Equity-300.86% Return on Assets-258.30% Debt Debt-to-Equity RatioN/A Current Ratio6.44 Quick Ratio5.99 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.02 per share Price / Book23.75Miscellaneous Outstanding Shares122,840,000Free FloatN/AMarket Cap$58.35 million OptionableNot Optionable Beta1.03 Don't wait for the SpaceX IPOThe space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (OTCMKTS:BLOZF) was last updated on 5/21/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredThe AI stocks about to become worthless (and one that isn't)Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cannabix Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cannabix Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
